Is 1 mg of Ozempic Good for Weight Loss?

Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Ozempic, reduces appetite and slows stomach emptying to help people lose weight. A 1 mg dose represents a maintenance level in the standard dosing progression, but whether it's optimal for you depends on your unique body chemistry and weight loss goals.

How Does 1 mg Semaglutide Work for Weight Loss?

At 1 mg, semaglutide activates GLP-1 receptors throughout your digestive system and brain, signaling fullness and reducing hunger intensity. This dose typically produces noticeable appetite suppression and modest metabolic changes after 4 to 8 weeks of consistent use. Most people following the standard titration reach the 1 mg maintenance dose after starting at 0.25 mg and escalating weekly.

Clinical trials show that patients on 1 mg semaglutide lose between 5 and 10 percent of body weight over 16 to 20 weeks when combined with lifestyle changes. The medication's effect on weight loss plateaus after about 6 months, meaning continued success relies on maintaining consistent dosing and healthy eating patterns. Individual responses vary widely based on genetics, metabolism, and how your body's peptide pathways respond to GLP-1 activation.

Is 1 mg Enough, or Do You Need a Higher Dose?

Whether 1 mg is sufficient depends on your starting weight, metabolic rate, and how your body responds to GLP-1 therapy. Some patients achieve meaningful weight loss at 1 mg, while others benefit from higher doses up to 2.4 mg or exploring dual-compound options like tirzepatide. Your healthcare provider typically evaluates your progress at 8 to 12 weeks to decide whether to continue or increase your dose.

PlexusDx offers flexibility beyond standard Ozempic dosing: compounded semaglutide can be customized to your response profile, and the Precision Peptide Genetic Test identifies how your GIPR genes influence medication effectiveness. This genetic insight helps determine whether 1 mg will be your optimal dose or whether a different strategy—such as oral semaglutide, tirzepatide, or a dual-compound approach—may produce better results.

Semaglutide 1 mg vs. Higher Doses: What the Evidence Shows

Ozempic clinical trials demonstrated that 1 mg produced average weight loss of 7 to 8 percent, while 2.4 mg doses achieved 10 to 12 percent loss. However, higher doses increase the risk of gastrointestinal side effects like nausea and vomiting, particularly during dose escalation weeks. The difference in outcome often reflects individual tolerability and adherence rather than absolute dose superiority.

Many patients find that 1 mg provides the sweet spot between meaningful weight loss and manageable side effects. Others discover that lower microdoses or oral formulations work better for their schedule and tolerance. PlexusDx Microdose GLP-1 Protocol at $129/month serves patients seeking gentler effects, while compounded Semaglutide Injection at $189/mo month-to-month, or from $149/mo on the 6-month plan allows dose flexibility based on real results.

Why Compounded Semaglutide May Outperform Standard Ozempic

Compounded semaglutide from licensed 503A pharmacies offers three key advantages: personalized dosing between standard increments, lower out-of-pocket cost ($149-$189/month depending on commitment tier), and no insurance gatekeeping or prior authorization delays. PlexusDx patients access the same pharmaceutical-grade semaglutide as Ozempic but with faster delivery and cost predictability—your dose may need to go up, but your price won't.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is 1 mg of semaglutide a good starting dose or a maintenance dose?

1 mg is a maintenance dose reached after a 4-week titration starting at 0.25 mg. It's not a starting point, but rather the dose where most patients achieve steady weight loss effects. If you're brand new to semaglutide, your provider will begin lower and escalate weekly to minimize nausea and maximize tolerance.

How much weight can I expect to lose on 1 mg semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

How much does semaglutide cost with PlexusDx compared to Ozempic?

PlexusDx compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) flat across all dose levels—meaning your price stays the same whether you need 0.5 mg or 2.4 mg. Brand-name Ozempic typically costs $900–$1,300/month without insurance, while PlexusDx includes no membership fees, serves all 50 states, and accepts HSA/FSA.

What are the side effects of 1 mg semaglutide, and are they serious?

Common side effects at 1 mg include mild nausea, constipation, and reduced appetite—most subside within 2–4 weeks. Serious side effects are rare but include pancreatitis risk in patients with a personal history. Always disclose your full medical history; PlexusDx providers review each patient's safety profile before dispensing.

Can genetic testing help me know if 1 mg will work for me?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Glp 1 For Weight Loss 2
• Glp 1 Weight Loss Before And After

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.